Perimeter Medical Imaging AI (PINK)

Executive Summary

Perimeter Medical Imaging AI is a medical device company developing real-time, AI-driven optical coherence tomography (OCT) imaging systems to improve surgical outcomes in oncology, initially targeting breast-conserving surgery. Its technology provides high-resolution visualization of tissue margins during surgery, helping surgeons achieve complete tumor removal and reduce repeat procedures. The company holds FDA 510(k) clearance for its imaging system and is advancing AI-integrated versions to automate margin assessment. Positioned at the intersection of AI, medical devices, and oncology, Perimeter addresses a significant unmet need in cancer surgery, where positive margins lead to additional surgeries and increased healthcare costs.

Upcoming Catalysts (preview)

• Q3 2026FDA clearance for next-generation AI-powered margin assessment system65% success
• Q3 2026Initiation of a pivotal clinical trial for expanded indication (e.g., lung or prostate cancer)50% success
• Q3 2026Strategic distribution partnership for US commercial expansion60% success